AJP - Endo Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab (September 8, 2009). doi:10.1152/ajpendo.00345.2009
This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Figures and Tables
Right arrow All Versions of this Article:
297/6/E1260    most recent
00345.2009v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Short, K. R.
Right arrow Articles by Nair, K. S.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Short, K. R.
Right arrow Articles by Nair, K. S.
Submitted on May 27, 2009
Revised on August 13, 2009
Accepted on August 17, 2009

Prednisone antagonizes insulin's anabolic effect on muscle protein and glucose metabolism

Kevin R. Short1, Maureen L Bigelow2, and K. Sreekumaran Nair2*

1 University of Oklahoma Health Sciences Center
2 Mayo Clinic

* To whom correspondence should be addressed. E-mail: nair.sree{at}mayo.edu.

Glucocorticoids causes muscle atrophy and weakness and but the mechanisms for these effects are unclear. The purpose of this study was to test a hypothesis that prednisone (Pred) counteracts insulin's anabolic effects on muscle. A randomized, double blind crossover design was used to test the effects of 6 days either Pred (0.8 mg/kg/d) or placebo use in 7 healthy young volunteers. Protein dynamics were measured across the leg using stable isotope tracers of leucine (Leu) and phenylalanine (Phe) after overnight fast and during a hyperinsulinemic (1.5 µU/min/kg FFM), euglycemic clamp with amino acid replacement. Fasting glucose, amino acids, insulin, and glucagon were higher (p<0.01) on Pred versus placebo while leg blood flow was 18% lower. However, basal whole body and leg kinetics of Leu and Phe were unaltered by Pred. Insulin infusion increased leg glucose uptake in both trials but was 65% lower with Pred than placebo. Insulin in both trials similarly suppressed whole body flux of Leu and Phe. Importantly, insulin increased net Leu and Phe balance across the leg, and the balance between muscle protein synthesis and breakdown, but these changes were 45-140% lower (p<0.03) in Pred than placebo. The present study demonstrates that short-term Pred use in healthy people does not alter whole body or leg muscle protein metabolism during the postabsoptive state but causes muscle insulin resistance for both glucose and amino acid metabolism, with a blunted protein anabolism. This interactive effect may lead to muscle atrophy with continued use of glucocorticoids.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2009 by the American Physiological Society.